Connect With the Companies Redefining ADC Payload Innovation

The 3rd ADC Payload Summit is the only industry forum dedicated exclusively to payload innovation, bringing together the scientists and decision-makers advancing next-generation ADC warheads, novel mechanisms of action, and differentiated linker-payload strategies. As the field moves beyond established cytotoxics, this is your opportunity to position your organization at the centre of the industry's most important payload development conversations.

In 2026, showcase your expertise to ADC developers actively seeking partners to accelerate payload discovery, optimize conjugate design, and translate novel mechanisms into clinically meaningful therapies. Connect with leaders looking for capabilities in:

  • Novel & Biology-Driven Payload Discovery
  • Payload Medicinal Chemistry & Optimization
  • Linker Design, Conjugation & ADC Engineering
  • Translational Modeling & Preclinical Evaluation
  • Analytical Development & Characterization
  • Process Development, Manufacturing & Scale-Up
  • Dual-Payload & Combination Strategy Development
  • Toxicology, DMPK & IND-Enabling Services

Position your brand alongside the innovators shaping the future of ADC payloads and build relationships with the companies driving the next wave of differentiated ADC therapies.

Networking Image (2) (1)

Top Reasons to Partner:

Access Decision Makers

Connect directly with senior scientists and R&D leaders from pharma and biotech companies actively advancing next-generation ADC payloads and seeking innovative partners.

Showcase Technical Leadership

Demonstrate your expertise in payload discovery, medicinal chemistry, linker-payload design, and ADC optimization to a highly targeted scientific audience.

Accelerate Business Development

Build relationships with prospective clients and collaborators through curated networking opportunities designed to foster meaningful technical and commercial discussions.

Position Your Innovation at the Forefront of ADC Development

Differentiate your capabilities and solutions among the companies shaping the future of payload innovation, novel mechanisms of action, and next-generation ADC therapeutics.

Key Services & Solutions

Attendees from across the ADC ecosystem are actively seeking partners with the expertise, technologies, and services needed to accelerate next-generation payload development, optimize linker-payload design, and advance novel mechanisms of action. Areas of interest include, but are not limited to:

  • Payload Providers/Technologies
  • Payload Development & Manufacturing
  • Medicinal Chemistry & Drug Discovery Services
  • Computational & Discovery Technologies
  • Therapeutic Cytotoxicity Profiling / In Vivo & In Vitro Testing
  • ADC Developers & Biopharma Innovators
Partner-With-Us[1]

Hear What Our Past Sponsors Have to Say

Exhibitor Logos (3)

Very high quality talks and open discussion” - Scientific Business Development Manager

Scientific Business Development Manager, Sygnature Discovery

klus pharma

A focused 3-day event providing insightful ideas, data, and discussion on the current landscape of ADC payloads, ways to improve upon existing molecules, and promoting research into new payload classes

Business Development Manager, Klus Pharma

18-768x432

Explore the Agenda

Discover the complete agenda featuring novel payload mechanisms, dual-payload ADCs, resistance biology, therapeutic index optimisation, and the industry leaders redefining ADC payload innovation.

1-768x432

Partner With the ADC Payload Community

Position your organization alongside 70+ senior payload, chemistry, biology, and translational R&D leaders actively seeking technologies, expertise, and collaborations to accelerate next-generation ADC development.

17-768x432

Join 70+ ADC Payload Leaders

Connect with scientists and decision-makers from biopharma and biotech companies tackling the industry's biggest challenges, from overcoming resistance and diversifying payloads to improving clinical translation.